Stay updated on PF-06463922 ALK/ROS1 Inhibitor Clinical Trial

Sign up to get notified when there's something new on the PF-06463922 ALK/ROS1 Inhibitor Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PF-06463922 ALK/ROS1 Inhibitor Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The Record History page shows updates only in its version list; no new content sections were added or removed.
    Difference
    0.1%
    Check dated 2025-11-03T21:21:09.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    32 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    7%
    Check dated 2025-10-06T05:57:07.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.2%
    Check dated 2025-09-29T03:12:46.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2, indicating a new release. The 'Back to Top' element was removed, a minor navigation change with no evident impact on core content.
    Difference
    0.4%
    Check dated 2025-09-14T19:54:18.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.4%
    Check dated 2025-09-07T16:55:23.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has added a facility name and location details, which are crucial for users seeking specific information about the study. Additionally, numerous updates to the study status and design have been included, reflecting ongoing changes in the study's progress.
    Difference
    92%
    Check dated 2025-08-31T12:09:02.000Z thumbnail image

Stay in the know with updates to PF-06463922 ALK/ROS1 Inhibitor Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PF-06463922 ALK/ROS1 Inhibitor Clinical Trial page.